In breast cancer patients, the cooperation of AF1q with TCF7 led to the transcription of CD44 [3], which is a WNT target gene that is essentially involved in tumor progression and epithelial-to-mesenchymal transition [34,35]. This evidence concerns the gene CD44 and breast cancer.